Medverus - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 746,145 | 678,266 | 860,963 | 749,854 | 1,182,180 | 1,611,429 | 1,805,029 | 2,044,891 |
| Profit before tax | 78,729 | 80,681 | 205,692 | 59,120 | 157,063 | 451,942 | 258,021 | 433,570 |
| Net profit | 78,729 | 80,681 | 205,692 | 59,120 | 157,063 | 416,438 | 258,021 | 364,730 |
| Equity | 430,228 | 510,909 | 716,611 | 740,444 | 897,507 | 1,231,592 | 1,200,047 | 1,200,071 |
| Liabilities | 554,585 | 455,190 | 558,154 | 399,099 | 758,415 | 484,039 | 936,136 | 847,787 |
| Non-current assets | 777,121 | 620,093 | 884,559 | 759,023 | 1,023,730 | 976,173 | 1,443,344 | 1,069,454 |
| Current assets | 237,946 | 346,006 | 447,071 | 380,520 | 724,275 | 739,458 | 693,989 | 978,404 |
| Total assets | 1,015,067 | 966,099 | 1,331,630 | 1,139,543 | 1,748,005 | 1,715,631 | 2,137,333 | 2,047,858 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 218,599 | 228,754 | 394,974 |
| Social insurance contributions | - | - | - | - | - | 67,126 | 75,153 | 84,014 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +67.0% | -9.1% | +26.9% | -12.9% | +57.7% | +36.3% | +12.0% | +13.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.8% | 8.4% | 15.4% | 5.2% | 9.0% | 24.3% | 12.1% | 17.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 18.3% | 15.8% | 28.7% | 8.0% | 17.5% | 33.8% | 21.5% | 30.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 10.6% | 11.9% | 23.9% | 7.9% | 13.3% | 25.8% | 14.3% | 17.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 10.6% | 11.9% | 23.9% | 7.9% | 13.3% | 28.0% | 14.3% | 21.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.3 | 0.9 | 0.8 | 0.5 | 0.8 | 0.4 | 0.8 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 52,361 | 50,554 | 56,457 | 53,561 | 81,530 | 103,963 | 114,002 | 128,475 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medverus - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-04-19 | 2022-04-21 | 575.87 |
| 2022-02-17 | 2022-02-21 | 454.41 |
| 2022-01-18 | 2022-01-18 | 402.52 |
Medverus - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medverus, UAB (code 126303062) is a Private Limited Liability Company operating in logging. In the latest financial year, 2025, the company generated revenue of €2.04M and net profit of €364.7K, with a profit margin of 17.8%. Revenue increased by 13.3% year on year and by 26.9% over two years, showing steady top-line growth. Profitability was weaker in 2024, when net profit fell to €258.0K from €416.4K in 2023, before recovering in 2025. The 2025 balance sheet shows total assets of €2.05M, equity of €1.20M and liabilities of €847.8K. The equity ratio stood at 58.6% and debt-to-equity at 0.71, indicating a solid capital structure. Asset turnover was 1.00x, while return on equity was 30.4% and return on assets 17.8%. With revenue per employee of €136.3K and profit per employee of €24.3K, the company shows meaningful operating productivity in 2025.